Profound Medical Corp Stock Overlap Studies Exponential Moving Average
| PROF Stock | USD 5.67 0.16 2.90% |
| Symbol |
Profound Medical Technical Analysis Modules
Most technical analysis of Profound Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Profound from various momentum indicators to cycle indicators. When you analyze Profound charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Methodology
Unless otherwise specified, financial data for Profound Medical Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Profound (USA Stocks:PROF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Profound Medical Corp has active sell-side coverage. Source-validated coverage currently shows 5 approved analysts, while broader market-consensus totals may differ across providers due to methodology and update timing. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, Goldman Sachs, Citigroup, Raymond James, Deutsche Bank, among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Michael Smolkin - Member of Macroaxis Board of DirectorsBe your own money manager
Generate Optimal Portfolios
Align your risk and return expectations
More Resources for Profound Stock Analysis
A structured review of Profound Medical Corp often starts with core financial statements and trend context. Ratio analysis helps investors evaluate Profound Medical Corp Stock operating efficiency and financial trajectory. Highlighted below are reports that provide context for Profound Medical Corp Stock: Earnings Share -1.32 | Revenue Per Share | Quarterly Revenue Growth 0.431 | Return On Assets | Return On Equity |